Drug Class
monoclonal antibody
Type
brand
Active Ingredient
inebilizumab
📋Overview
Uplizna is a monoclonal antibody medication that targets a specific protein on immune cells called CD19. It is primarily associated with the treatment of certain autoimmune conditions that affect the central nervous system, such as neuromyelitis optica spectrum disorder (NMOSD). By modulating the immune response, Uplizna helps reduce inflammation and damage to nerve cells. Its use is generally reserved for individuals with specific antibody-positive forms of these disorders.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Uplizna
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.